117 related articles for article (PubMed ID: 3627097)
1. [Estrogen receptor kinetics in benign and malignant diseases of the breast and their clinical implication].
Ebuchi M
Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):746-54. PubMed ID: 3627097
[TBL] [Abstract][Full Text] [Related]
2. Relationship of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer.
Romić-Stojković R; Gamulin S
Cancer Res; 1980 Dec; 40(12):4821-5. PubMed ID: 7438115
[TBL] [Abstract][Full Text] [Related]
3. Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer.
Waseda N; Kato Y; Imura H; Kurata M
Cancer Res; 1981 May; 41(5):1984-8. PubMed ID: 7214366
[TBL] [Abstract][Full Text] [Related]
4. [Incidence and importance of nuclear estradiol receptors in human breast cancer].
Dietrich W
Arch Geschwulstforsch; 1982; 52(8):667-83. PubMed ID: 6762860
[TBL] [Abstract][Full Text] [Related]
5. Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors.
Thorpe SM
Cancer Res; 1987 Apr; 47(7):1830-5. PubMed ID: 3545455
[TBL] [Abstract][Full Text] [Related]
6. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival in primary breast cancer: correlation with estrogen and progesterone receptor assay results and adjuvant tamoxifen therapy.
Chrapusta SJ; Giermek J; Pieńkowski T
Med Sci Monit; 2004 Oct; 10(10):CR577-86. PubMed ID: 15448598
[TBL] [Abstract][Full Text] [Related]
8. [Content of 17 beta éstradiol, progesterone and glucocorticoid receptors in patients with benign breast diseases].
Bassalyk LS; Kuz'mina ZV; Murav'eva NI; Smirnova KD; Vishniakova VV
Vopr Onkol; 1982; 28(7):3-6. PubMed ID: 7101825
[TBL] [Abstract][Full Text] [Related]
9. [Experimental and clinical study on endocrine therapy of breast carcinoma, with special reference to the nuclear estrogen receptor].
Kubouchi K
Nihon Geka Gakkai Zasshi; 1984 Nov; 85(11):1405-17. PubMed ID: 6521721
[TBL] [Abstract][Full Text] [Related]
10. [Endocrine differences between patients with luteal phase deficiency and inadequate endometrial response].
Xu M; Zhang Z; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):141-4. PubMed ID: 9596886
[TBL] [Abstract][Full Text] [Related]
11. [Studies on estradiol occupied and unoccupied receptors in human endometrial cytosol and nucleus: steroid receptors throughout the menstrual cycle and in cases of oral contraceptives administration (author's transl)].
Azumaguchi A; Tanaka S
Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):951-60. PubMed ID: 7304137
[TBL] [Abstract][Full Text] [Related]
12. [Estrogen receptor in human breast cancer: relationship between the receptor contents and the histological and cytomorphological characteristics].
Kimura M
Nihon Geka Gakkai Zasshi; 1984 Aug; 85(8):763-72. PubMed ID: 6493199
[TBL] [Abstract][Full Text] [Related]
13. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Dell'Orto P; Rasmussen BB; Raffoul J; Neven P; Orosz Z; Braye S; Ohlschlegel C; Thürlimann B; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2007 Sep; 25(25):3846-52. PubMed ID: 17679725
[TBL] [Abstract][Full Text] [Related]
15. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
[TBL] [Abstract][Full Text] [Related]
16. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients.
Yu KD; Liu GY; Di GH; Wu J; Lu JS; Shen KW; Shen ZZ; Shao ZM
Breast; 2007 Jun; 16(3):307-15. PubMed ID: 17293115
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and progesterone receptor status in breast cancer in Kuwait female population.
Paszko Z; Omar YT; Nasralla MY; Jazzaf H; Bouzubar N; Temmim L; Padzik H
Neoplasma; 1993; 40(2):127-32. PubMed ID: 8350956
[TBL] [Abstract][Full Text] [Related]
19. Occupied and unoccupied nuclear oestradiol receptor in human breast tumours: relation to oestradiol and progesterone cytosol receptors.
Thorsen T
J Steroid Biochem; 1979 Jun; 10(6):661-8. PubMed ID: 470389
[No Abstract] [Full Text] [Related]
20. [Experimental study on the determination of estrogen receptor and the effect of antiestrogen therapy in breast cancer].
Imamura H
Nihon Geka Gakkai Zasshi; 1991 Oct; 92(10):1493-502. PubMed ID: 1961187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
